bonyf NV · ISIN: BE6333353298 · EQS - Company News

bonyf R&D presents its two latest innovations at IDS 2025 in Cologne

bonyf NV / Key word(s): Product Launch/Market Launch bonyf R&D presents its two latest innovations at IDS 2025 in Cologne 30-Jan-2025 / 23:21 CET/CEST bonyf R&D presents its two latest innovations at IDS 2025 in Cologne Knokke-Heist (Belgium), 30 January 2025, 6:00 p.m.; bonyf NV (Mnemonic: MLBON), the next-generation oral comfort expert, is a Euronext Paris listed company and specializes in the development, production, and marketing of ora...

Corporate Insights - Short Sales, Director's Dealings, Sentiment Indicators - THE info hub for the informed investor

Smart tools for smart investors can be found in our Tools section

Corporate News bonyf NV

In this overview you can view company news in the chronological order of publication. The source information comes from EQS News, the leading European news distributor. The most recent news item is listed first.
30 January 2025 11:21PM
bonyf R&D presents its two latest innovations at IDS 2025 in Cologne
bonyf NV / Key word(s): Product Launch/Market Launch bonyf R&D presents its two latest innovations at IDS 2025 in Cologne 30-Jan-2025 / 23:21 CET/CEST bonyf R&D presents its two latest innovations at IDS 2025 in Cologne Knokke-Heist (Belgium), 30 January 2025, 6:00 p.m.; bonyf NV (Mnemonic: ML...
bonyf NV
30 January 2025 11:21PM
bonyf R&D presents its two latest innovations at IDS 2025 in Cologne
bonyf NV / Key word(s): Product Launch/Market Launch bonyf R&D presents its two latest innovations at IDS 2025 in Cologne 30-Jan-2025 / 23:21 CET/CEST bonyf R&D presents its two latest innovations at IDS 2025 in Cologne Knokke-Heist (Belgium), 30 January 2025, 6:00 p.m.; bonyf NV (Mnemonic: ML...
bonyf NV
10 December 2024 03:31PM
bonyf and Honest Pharma are pleased to announce a Strategic Alliance to bring revolutionary oral care products to the US market
bonyf NV / Key word(s): Alliance/Investment bonyf and Honest Pharma are pleased to announce a Strategic Alliance to bring revolutionary oral care products to the US market 10-Dec-2024 / 15:31 CET/CEST bonyf and Honest Pharma are pleased to announce a Strategic Alliance to bring revolutionary oral care products to the US m...
bonyf NV
09 December 2024 03:42PM
bonyf Achieves MDR Certification, Strengthening Commitment to Excellence in Oral Care Solutions
bonyf NV / Key word(s): Regulatory Admission/Regulatory Approval bonyf Achieves MDR Certification, Strengthening Commitment to Excellence in Oral Care Solutions 09-Dec-2024 / 15:42 CET/CEST bonyf Achieves MDR Certification, Strengthening Commitment to Excellence in Oral Care Solutions Knokke-Heist (Be...
bonyf NV
28 November 2024 11:20AM
bonyf expands its global formulation footprint through a strategic alliance with Group Pharmaceuticals Ltd, signing a license agreement to produce NitrAdine® for India
bonyf NV / Key word(s): Alliance/Agreement bonyf expands its global formulation footprint through a strategic alliance with Group Pharmaceuticals Ltd, signing a license agreement to produce NitrAdine® for India 28-Nov-2024 / 11:20 CET/CEST bonyf expands its global NitrAdine® formulation footprint through its latest strate...
bonyf NV
24 October 2024 11:48AM
PerioTabs Innovative 10-Day NitrAdine-Based Treatment to Revolutionize Oral Care
bonyf NV / Key word(s): Product Launch/Research Update PerioTabs Innovative 10-Day NitrAdine-Based Treatment to Revolutionize Oral Care 24-Oct-2024 / 11:48 CET/CEST PerioTabs®: Innovative 10-Day NitrAdine®-Based Treatment to Revolutionize Oral Care Effervescent tablet offers a unique approach to treating gum and impla...
bonyf NV
More bonyf NV related information
Type Total Last Made by Go to
Corporate Research 0 - - Corporate Research
Directors Dealings 0 - - DD
Short Seller (DE) 0 - - SSR (DE)
Short Seller (UK) 0 - - SSR (UK)
Disclaimer:

The combination of information with graphic elements makes an important contribution to visual orientation and navigation through complex factual topics. Essential content features can be perceived, grasped and contextually processed much faster. 
The figurative marks, logos and other graphic and textual elements used on this website are for illustrative purposes only. All rights to the aforementioned elements are held by their respective owners. They are used without the intention of copyright infringement or intellectual property infringement.

If you believe that copyrights or intellectual property have been infringed by the choice of illustration, please contact us immediately to clarify the issue.

v.07062023 EN